291 related articles for article (PubMed ID: 23673666)
21. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
22. New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain.
Dumoutier L; de Meester C; Tavernier J; Renauld JC
J Biol Chem; 2009 Sep; 284(39):26377-84. PubMed ID: 19632985
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
24. RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression.
Meyer Zu Horste G; Wu C; Wang C; Cong L; Pawlak M; Lee Y; Elyaman W; Xiao S; Regev A; Kuchroo VK
Cell Rep; 2016 Jul; 16(2):392-404. PubMed ID: 27346359
[TBL] [Abstract][Full Text] [Related]
25. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
[TBL] [Abstract][Full Text] [Related]
26. Pilot study of variants of the IL-23R and STAT3 genes reveals no association with Hashimoto's thyroiditis in the Croatian population.
Stevic MS; Stefanic M; Tokic S; Glavas-Obrovac L; Mihaljevic S; Karner I
Endocr Res; 2014; 39(4):164-7. PubMed ID: 24460100
[TBL] [Abstract][Full Text] [Related]
27. IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity.
Lee PW; Smith AJ; Yang Y; Selhorst AJ; Liu Y; Racke MK; Lovett-Racke AE
JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878115
[TBL] [Abstract][Full Text] [Related]
28. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.
Demoulin JB; Uyttenhove C; Van Roost E; DeLestré B; Donckers D; Van Snick J; Renauld JC
Mol Cell Biol; 1996 Sep; 16(9):4710-6. PubMed ID: 8756628
[TBL] [Abstract][Full Text] [Related]
29. Human CD39
Magid-Bernstein JR; Rohowsky-Kochan CM
J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
[TBL] [Abstract][Full Text] [Related]
30. The amino acid residues immediately carboxyl-terminal to the tyrosine phosphorylation site contribute to interleukin 6-specific activation of signal transducer and activator of transcription 3.
Inoue M; Minami M; Matsumoto M; Kishimoto T; Akira S
J Biol Chem; 1997 Apr; 272(14):9550-5. PubMed ID: 9083098
[TBL] [Abstract][Full Text] [Related]
31. IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance.
Basu R; Whitley SK; Bhaumik S; Zindl CL; Schoeb TR; Benveniste EN; Pear WS; Hatton RD; Weaver CT
Nat Immunol; 2015 Mar; 16(3):286-95. PubMed ID: 25642823
[TBL] [Abstract][Full Text] [Related]
32. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
Tanuma N; Shima H; Nakamura K; Kikuchi K
Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
[TBL] [Abstract][Full Text] [Related]
33. Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.
Miralles M; Eixarch H; Tejero M; Costa C; Hirota K; Castaño AR; Puig M; Stockinger G; Montalban X; Bosch A; Espejo C; Chillon M
Neurotherapeutics; 2017 Oct; 14(4):1095-1106. PubMed ID: 28593439
[TBL] [Abstract][Full Text] [Related]
34. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor.
Li J; Zhang L; Zhang J; Wei Y; Li K; Huang L; Zhang S; Gao B; Wang X; Lin P
Carcinogenesis; 2013 Mar; 34(3):658-66. PubMed ID: 23250909
[TBL] [Abstract][Full Text] [Related]
36. Distinctive expression of interleukin-23 receptor subunits on human Th17 and γδ T cells.
Wines BD; Yap ML; Powell MS; Tan PS; Ko KK; Orlowski E; Hogarth PM
Immunol Cell Biol; 2017 Mar; 95(3):272-279. PubMed ID: 27645493
[TBL] [Abstract][Full Text] [Related]
37. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J
J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870
[TBL] [Abstract][Full Text] [Related]
38. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
39. T-bet over-expression regulates aryl hydrocarbon receptor-mediated T helper type 17 differentiation through an interferon (IFN)γ-independent pathway.
Yokosawa M; Kondo Y; Tahara M; Iizuka-Koga M; Segawa S; Kaneko S; Tsuboi H; Yoh K; Takahashi S; Matsumoto I; Sumida T
Clin Exp Immunol; 2017 Apr; 188(1):22-35. PubMed ID: 27936495
[TBL] [Abstract][Full Text] [Related]
40. Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.
Wilmes S; Jeffrey PA; Martinez-Fabregas J; Hafer M; Fyfe PK; Pohler E; Gaggero S; López-García M; Lythe G; Taylor C; Guerrier T; Launay D; Mitra S; Piehler J; Molina-París C; Moraga I
Elife; 2021 Apr; 10():. PubMed ID: 33871355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
